Herein, we identify important areas of controversy and open research questions in the field of immune-related toxicity. Michael Conroy Jarushka Naidoo CommentOpen Access19 Jan 2022 Nature Communications Towards evidence-based response criteria for cancer immunotherapy Early detection of immunotherapy-...
英国期刊Journal for ImmunoTherapy of Cancer,创刊于2013年,是肿瘤免疫治疗学会(Society for Immunotherapy of Cancer)的官方期刊,曾由BioMed Central出版集团出版,2020年1月起正式转至BMJ旗下,主要关注肿瘤免疫学与癌症免疫治疗等方面的基础、临床研究。 Journal for ImmunoTherapy of Cancer杂志主编是瑞士路德维希癌症研究...
This work was supported by the Intramural Research Program of the Center for Cancer Research, US National Cancer Institute (NCI), National Institutes of Health. The authors would like to thank C. Klebanoff, L. Gattinoni, C. Hinrichs and P. Muranski for discussions about T cell differentiation,...
For many types of cancer, immunotherapy, a type of biologic therapy, has been a game changer. Why? Precision medicine is at the heart of immunotherapy, currently one of the hottest areas of cancer research. Immunotherapy is a new approach that harnesses the power of our immune systems to ide...
"We've developed a high-throughput method to identify mutations present in a cancer that are recognized by the immune system," said Steven A. Rosenberg, chief of the Surgery Branch at NCI's Center for Cancer Research (CCR). "This research is experimental right now. But because this new ap...
Post AACR Blog #2: Cancer Immunotherapy The ability to mobilize the immune system to fight cancer has revolutionized the way we treat this disease. It’s no surprise that Cancer Immunotherapy was a prominent topic at the 2017 American Association for Cancer Research (AACR) annual meeting. ...
The signal pathways, functions for cancer immunotherapy of TNFR2, as well as binding modes of the antibody-TNFR2 complex have been discussed in detailed. Moreover, the latest research progress involving TNFR2 antibody therapy is also summarized. Although the development of TNFR2-targeted drugs is...
repositories will become extraordinarily valuable as the proportion of single-cell data they hold increases. With rich collaboration resources, viable multi-omics approaches, and practical single-cell analysis solutions to the problem of tumor heterogeneity, cancer immunotherapy research is ...
Abstract Immunotherapy has shown promise in many solid tumors including melanoma and non-small cell lung cancer with an evolving role in breast cancer. Immunotherapy encompasses a wide range of therapies including immune checkpoint inhibition, monoclonal antibodies, bispecific antibodies, vaccinations, antibo...
Research Highlights31 Jan 2025Nature Immunology Volume: 26, P: 149 Unlocking the potential of engineered immune cell therapy for solid tumors Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of r...